You are here

  • Home
  • Archive
  • Volume 7, Issue 1
  • The role of PD-L1 expression as a predictive biomarker: an analysis of all US Food and Drug Administration (FDA) approvals of immune checkpoint inhibitors

Article info

Article menu

Download PDFPDF

XML
Short Report
The role of PD-L1 expression as a predictive biomarker: an analysis of all US Food and Drug Administration (FDA) approvals of immune checkpoint inhibitors

Authors

  • Andrew A. Davis Division of Hematology and Oncology, Department of MedicineNorthwestern University Feinberg School of Medicine Chicago IL USA Robert H. Lurie Comprehensive Cancer Center of Northwestern University Chicago IL USA PubMed articlesGoogle scholar articles
  • Vaibhav G. Patel Division of Hematology and Medical OncologyTisch Cancer Institute, Icahn School of Medicine at Mount Sinai 1 Gustave Levy Library Place 10029 New York NY USA PubMed articlesGoogle scholar articles
  1. ↵b 212-241-6756 vaibhav.patel{at}mountsinai.org
View Full Text

Citation

Davis AA, Patel VG
The role of PD-L1 expression as a predictive biomarker: an analysis of all US Food and Drug Administration (FDA) approvals of immune checkpoint inhibitors
Journal for ImmunoTherapy of Cancer 2019;7:278. doi: 10.1186/s40425-019-0768-9

Publication history

  • Received May 28, 2019
  • Accepted October 5, 2019
  • First published October 26, 2019.
Online issue publication 
January 08, 2022

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© The Author(s). Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.